126 related articles for article (PubMed ID: 19536085)
1. Hyperglycemic kidney damage in an animal model of prolonged critical illness.
Vanhorebeek I; Gunst J; Ellger B; Boussemaere M; Lerut E; Debaveye Y; Rabbani N; Thornalley PJ; Schetz M; Van den Berghe G
Kidney Int; 2009 Sep; 76(5):512-20. PubMed ID: 19536085
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.
Vanhorebeek I; Ellger B; De Vos R; Boussemaere M; Debaveye Y; Perre SV; Rabbani N; Thornalley PJ; Van den Berghe G
Crit Care Med; 2009 Apr; 37(4):1355-64. PubMed ID: 19242345
[TBL] [Abstract][Full Text] [Related]
3. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
[TBL] [Abstract][Full Text] [Related]
4. Impact of hyperglycemia on neuropathological alterations during critical illness.
Sonneville R; den Hertog HM; Güiza F; Gunst J; Derese I; Wouters PJ; Brouland JP; Polito A; Gray F; Chrétien F; Charlier P; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
J Clin Endocrinol Metab; 2012 Jun; 97(6):2113-23. PubMed ID: 22442271
[TBL] [Abstract][Full Text] [Related]
5. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
[TBL] [Abstract][Full Text] [Related]
6. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
Ellger B; Richir MC; van Leeuwen PA; Debaveye Y; Langouche L; Vanhorebeek I; Teerlink T; Van den Berghe G
Endocrinology; 2008 Jun; 149(6):3148-57. PubMed ID: 18292189
[TBL] [Abstract][Full Text] [Related]
7. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
8. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
[TBL] [Abstract][Full Text] [Related]
9. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Ellger B; Debaveye Y; Vanhorebeek I; Langouche L; Giulietti A; Van Etten E; Herijgers P; Mathieu C; Van den Berghe G
Diabetes; 2006 Apr; 55(4):1096-105. PubMed ID: 16567534
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
Langouche L; Mesotten D; Vanhorebeek I
Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
[TBL] [Abstract][Full Text] [Related]
11. Insufficient autophagy contributes to mitochondrial dysfunction, organ failure, and adverse outcome in an animal model of critical illness.
Gunst J; Derese I; Aertgeerts A; Ververs EJ; Wauters A; Van den Berghe G; Vanhorebeek I
Crit Care Med; 2013 Jan; 41(1):182-94. PubMed ID: 23222264
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice.
Sonneville R; Derese I; Marques MB; Langouche L; Derde S; Chatre L; Chrétien F; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
Shock; 2015 Sep; 44(3):245-51. PubMed ID: 26009823
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycaemia emerging during general anaesthesia induces rat acute kidney injury via impaired microcirculation, augmented apoptosis and inhibited cell proliferation.
Efrati S; Berman S; Hamad RA; Siman-Tov Y; Chanimov M; Weissgarten J
Nephrology (Carlton); 2012 Feb; 17(2):111-22. PubMed ID: 22066573
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
[TBL] [Abstract][Full Text] [Related]
15. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2012 Jan; 97(1):E59-64. PubMed ID: 22013100
[TBL] [Abstract][Full Text] [Related]
17. Macula densa morphology in diabetic rats with and without hyperglycemia and in nondiabetic hyperglycemic rats.
Rasch R; Holck P
Lab Invest; 1991 Mar; 64(3):392-9. PubMed ID: 2002656
[TBL] [Abstract][Full Text] [Related]
18. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
Weekers F; Giulietti AP; Michalaki M; Coopmans W; Van Herck E; Mathieu C; Van den Berghe G
Endocrinology; 2003 Dec; 144(12):5329-38. PubMed ID: 12960028
[TBL] [Abstract][Full Text] [Related]
19. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
20. Causes and consequences of hyperglycemia in critical illness.
Falciglia M
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):498-503. PubMed ID: 17563470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
